Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Degrees

Yale University, BS 1996
Biology

Companies

CEO and Co-founder

Former Financial Organizations

Healthcare Analyst
Analyst

Web Presences

Tags

Photo Credit

Makers.com

Anne Wojcicki

Anne brings to 23andMe a 10-year background in healthcare investing, focused primarily on biotechnology companies. Anne left the investing world with the hope that she could have a positive impact on research and medicine through 23andMe. From her vantage point, Anne saw a need for creating a way to generate more information - especially more personalized information - so that commercial and academic researchers could better understand and develop new drugs and diagnostics. By encouraging individuals to access and learn about their own genetic information, 23andMe will create a common, standardized resource that has the potential to accelerate drug discovery and bring personalized medicine to the public. (Plus, getting access to her own genetic information and understanding it has always been one of Anne’s ambitions.) Anne graduated from Yale University with a B.S. in biology.

Recent Milestones

Investments

Company Date Round Size Participants
23andMe 12/2012Series D$57.9M6

Videos


Sources

  1. sec.gov [edit]
Edit This Page
Last Edited 3/26/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

TechCrunch Posts TechCrunch Logo Small Picture

Techmeme Posts Techmeme Logo Small Picture

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy